614 related articles for article (PubMed ID: 26178990)
1. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes.
Schleiss MR; Fernández-Alarcón C; Hernandez-Alvarado N; Wang JB; Geballe AP; McVoy MA
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960639
[TBL] [Abstract][Full Text] [Related]
3. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
[TBL] [Abstract][Full Text] [Related]
4. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
[TBL] [Abstract][Full Text] [Related]
5. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
6. An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.
Schleiss MR; Buus R; Choi KY; McGregor A
Future Virol; 2013 Dec; 8(12):1151-1160. PubMed ID: 24465269
[TBL] [Abstract][Full Text] [Related]
7. A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.
Choi KY; Root M; McGregor A
J Virol; 2016 Sep; 90(17):7902-19. PubMed ID: 27334585
[TBL] [Abstract][Full Text] [Related]
8. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.
Choi KY; McGregor A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452332
[TBL] [Abstract][Full Text] [Related]
9. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
Choi KY; El-Hamdi NS; McGregor A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.
Schleiss MR; Choi KY; Anderson J; Mash JG; Wettendorff M; Mossman S; Van Damme M
Vaccine; 2014 May; 32(23):2756-62. PubMed ID: 23867012
[TBL] [Abstract][Full Text] [Related]
12. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
[TBL] [Abstract][Full Text] [Related]
13. Repair of a Mutation Disrupting the Guinea Pig Cytomegalovirus Pentameric Complex Acquired during Fibroblast Passage Restores Pathogenesis in Immune-Suppressed Guinea Pigs and in the Context of Congenital Infection.
McVoy MA; Wang JB; Dittmer DP; Bierle CJ; Swanson EC; Fernández-Alarcón C; Hernandez-Alvarado N; Zabeli JC; Schleiss MR
J Virol; 2016 Sep; 90(17):7715-27. PubMed ID: 27307567
[TBL] [Abstract][Full Text] [Related]
14. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
Schleiss MR; Bourne N; Bernstein DI
J Infect Dis; 2003 Dec; 188(12):1868-74. PubMed ID: 14673766
[TBL] [Abstract][Full Text] [Related]
15. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
Schleiss MR; Stroup G; Pogorzelski K; McGregor A
Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
[TBL] [Abstract][Full Text] [Related]
16. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
Schleiss MR; Lacayo JC; Belkaid Y; McGregor A; Stroup G; Rayner J; Alterson K; Chulay JD; Smith JF
J Infect Dis; 2007 Mar; 195(6):789-98. PubMed ID: 17299708
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against transplacental cytomegalovirus transmission: vaccine reactivation and efficacy in guinea pigs.
Bia FJ; Miller SA; Lucia HL; Griffith BP; Tarsio M; Hsiung GD
J Infect Dis; 1984 Mar; 149(3):355-62. PubMed ID: 6325549
[TBL] [Abstract][Full Text] [Related]
18. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
[TBL] [Abstract][Full Text] [Related]
19. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model.
Harrison CJ; Britt WJ; Chapman NM; Mullican J; Tracy S
J Infect Dis; 1995 Nov; 172(5):1212-20. PubMed ID: 7594656
[TBL] [Abstract][Full Text] [Related]
20. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
Schleiss MR
J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
